1 citations
,
November 2020 in “Cureus” This study found that severity of female pattern hair loss in premenopausal women was related to other clinical signs of hyperandrogenism like hirsutism and acne, but not to biochemical measures of hyperandrogenism.
1 citations
,
October 2020 in “PubMed” In this study, nearly half of the female patients with androgenetic alopecia reported symptoms of hormonal disorders, but hormone test results did not show significant abnormalities.
5 citations
,
May 2020 in “Diagnostics” This study involving male patients with androgenic alopecia found that a higher baseline zinc plasma level, specifically above 10 µmol/L, may predict the success of treatment with 5% topical minoxidil, correlating with increased hair density and diameter in the parietal area.
4 citations
,
April 2020 in “Journal of Cosmetic Dermatology” This study found that Chinese patients with alopecia areata, female pattern hair loss, and male androgenetic alopecia had significantly lower serum vitamin D levels than healthy individuals.
1 citations
,
December 2019 in “Journal of skin and stem cell” This study found no significant immediate hair growth or loss reduction from PRP treatment compared to Finastride and placebo, but differences emerged after three to six months.
January 2019 in “Menoufia Medical Journal” This study found that women with female pattern hair loss had significantly lower serum vitamin D levels than healthy controls, suggesting a possible role of vitamin D deficiency in the condition.
2 citations
,
December 2018 in “Қазақстанның клиникалық медицинасы” This study found that individuals with androgenic alopecia had higher levels of vitamin D compared to those with telogen effluvium and healthy controls.
July 2018 in “Benha Journal of Applied Sciences” This study found that patients with androgenetic alopecia had higher serum homocysteine levels, which were positively correlated with BMI and smoking, suggesting it could be an early predictor for AGA diagnosis.
July 2016 in “International journal of biomedical research” This study found that among men with androgenetic alopecia, increased DHEA-S levels were significantly associated with greater clinical severity, although testosterone levels were generally normal.
23 citations
,
January 2016 in “International Journal of Trichology” This study found that women with female pattern hair loss had significantly lower serum Vitamin D3 levels compared to healthy controls.
37 citations
,
March 2014 in “Journal of Trace Elements in Medicine and Biology” This study reported that Turkish males with male pattern androgenetic alopecia had significantly lower zinc and copper levels in their hair compared to healthy controls, suggesting these imbalances may play a role in the condition's etiology.
April 2012 in “Journal of IMAB” This study found no correlation between clinical stages of androgenetic alopecia and serum DHEA-S levels in men, contrasting with previous studies suggesting elevated levels.
10 citations
,
January 2012 in “International Journal of Trichology” This study found no significant association between serum levels of vitamin B12, folate, TSH, ferritin, zinc, or anxiety scores and trichodynia in telogen alopecia patients.
1 citations
,
January 2008 in “Actas Dermo-Sifiliográficas” This review discusses clinical variations, laboratory testing, and treatments for female-pattern alopecia, including finasteride, but reports no new clinical findings; the authors emphasize managing stress and psychological impacts.
43 citations
,
January 2007 in “Gynecological Endocrinology” This study found that 9 out of 12 women with acne or alopecia showed subjective improvement with finasteride treatment despite having normal free testosterone levels, suggesting a potential role of 5alpha-reductase activity.
June 2003 in “Obstetrical & Gynecological Survey” Hair loss in women can be treated with hormone therapy.
47 citations
,
December 2000 in “Archives of Dermatological Research” This study found that women with androgenetic alopecia showed higher levels of certain hormones and lower levels of sex hormone-binding globulin than healthy controls, potentially linking these factors to alopecia severity.
124 citations
,
August 1990 in “British Journal of Dermatology” Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.
25 citations
,
April 1988 in “Geburtshilfe und Frauenheilkunde” In this study, treatment targeting the estrogen-androgen balance reduced hair loss in 74 out of 104 women with androgenetic alopecia, with some experiencing hair regrowth.